Table 5. Participant usage and satisfaction.
Question | NRT group | END group | p |
---|---|---|---|
Day of surgery | (n = 10) | (n = 19) | |
Used product daily or most days, n (%) | 5 (50%) | 11 (58%) | 0.71 |
Agreement (Likert scale 1–7) with | |||
“The product is helpful for quitting smoking,” median [IQR] | 5 [3–7] | 6 [4-7] | 0.59 |
“I was satisfied with the product to help with quitting,” median [IQR] | 5 [3–6] | 6 [4–6] | 0.71 |
“I would recommend the product to someone interested in quitting smoking,” median [IQR] | 6 [5–7] | 6 [6–7] | 0.73 |
8-weeks after randomization | (n = 9) | (n = 20) | |
Used product daily or most daysa, n(%) | 6 (67%) | 16 (80%) | 0.64 |
Agreement (Likert scale 1–7) with | |||
“The product is helpful for quitting smoking,” median [IQR] | 5 [3–7] | 6 [4–7] | 0.79 |
“I was satisfied with the product to help with quitting,” median [IQR] | 5 [3–6] | 5.5 [2.5–7] | 0.67 |
“I would recommend the product to someone interested in quitting smoking,” median [IQR] | 7 [6–7] | 6 [5–7] | 0.46 |
Notes.
p-value from Fisher’s exact test for product usage and Wilcoxon ranksum test for all other values. Likert scale was used for agreement (1 = strongly disagree, 2 = disagree, 3 = disagree somewhat, 4 = neither agree nor disagree, 5 = agree somewhat, 6 = agree, 7 = strongly agree).
- NRT
- nicotine replacement therapy
- END
- electronic nicotine delivery (e-cigarette). IQR = interquartile range
Asked about use while supplies lasted (e.g., considered the participant to have used the product daily or most days if they used the product until they ran out).